We retrospectively evaluated 54 results of the SeptiFast test from patients with solid malignancy admitted to the ICU between June 2009 and August 2011. Specimens from suspected bloodstream infection were analyzed using LightCycler SeptiFast (Roche Molecular Diagnostics, Prague, Czech Republic) according to the manufacturer's instructions and evaluated in comparison with blood culture results obtained from blood sampled no longer than 24 hours before or after sampling for SeptiFast. Blood culturing and identifi cation were performed according to the routine diagnostic procedures. Th e total number of complementary blood cultures analyzed was 85. Consistently, negative results from SeptiFast and blood culture were obtained in 21 (39%) cases.
To assess the true positivity of both microbiological methods, discrepant cases were evaluated in the context of clinical and laboratory fi ndings by two independent physicians experienced in critical care ( Figure 1 ). Th e clinically relevant presence of a pathogen detected by blood culture but not by SeptiFast was recorded for Klebsiella pneumoniae/oxytoca, and in both cases the presence of another member of Enterobacteriaceae was reported by SeptiFast, Escherichia coli and Enterobacter cloacae/aerogenes -thus misidentifi cation of strains with atypical phenotype cannot be excluded [3] . Our results also show that SeptiFast is more effi cient in detection of clinically relevant infection by E. coli and Pseudomonas aeruginosa.
Th e turnaround time for blood culture analysis is 24 to 48 hours. Th e workfl ow in our laboratory allows SeptiFast analysis every working day during a day shift. In such conditions, the turnaround time of SeptiFast results for samples delivered to the laboratory on a workday between 7 am and 2 pm was as follows: 100% of samples, 10 hours; 97% of samples, 8 hours; 59% of samples, 6 hours. Th e average turn around time for tests performed with manual DNA isolation was 6 hours 11 minutes; by implementation of automated isolation of DNA using the MagNA Pure Compact System [4] , the mean turnaround time was shortened to 5 hours 17 minutes.
In conclusion, detection of pathogen by the LightCycler SeptiFast system is generally not inferior to the results from blood culture. Th e added value of multiplex DNA amplifi cation-based pathogen detection is the shorter test turnaround time and probably the increased true sensitivity of detection of certain pathogens. Moreover, in clinical settings pathogen detection may be required after an antibiotic administration; in such conditions, cultivation independent methods are of clear benefi t [5] .
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